HomeCompareJSNSF vs JNJ

JSNSF vs JNJ: Dividend Comparison 2026

JSNSF yields 6.96% · JNJ yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JSNSF wins by $1518.14M in total portfolio value
10 years
JSNSF
JSNSF
● Live price
6.96%
Share price
$4.75
Annual div
$0.33
5Y div CAGR
84.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1518.17M
Annual income
$1,428,367,236.01
Full JSNSF calculator →
JNJ
Johnson & Johnson
● Live price
2.14%
Share price
$242.49
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.5K
Annual income
$4,749.88
Full JNJ calculator →

Portfolio growth — JSNSF vs JNJ

📍 JSNSF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodJSNSFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, JSNSF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
JSNSF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

JSNSF
Annual income on $10K today (after 15% tax)
$591.42/yr
After 10yr DRIP, annual income (after tax)
$1,214,112,150.61/yr
JNJ
Annual income on $10K today (after 15% tax)
$182.28/yr
After 10yr DRIP, annual income (after tax)
$4,037.40/yr
At 15% tax rate, JSNSF beats the other by $1,214,108,113.21/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of JSNSF + JNJ for your $10,000?

JSNSF: 50%JNJ: 50%
100% JNJ50/50100% JSNSF
Portfolio after 10yr
$759.10M
Annual income
$714,185,992.94/yr
Blended yield
94.08%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

JSNSF
No analyst data
Altman Z
4.2
Piotroski
7/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-5.7% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

JSNSF buys
0
JNJ buys
0
No recent congressional trades found for JSNSF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricJSNSFJNJ
Forward yield6.96%2.14%
Annual dividend / share$0.33$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR84.2%28%
Portfolio after 10y$1518.17M$30.5K
Annual income after 10y$1,428,367,236.01$4,749.88
Total dividends collected$1511.64M$15.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: JSNSF vs JNJ ($10,000, DRIP)

YearJSNSF PortfolioJSNSF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,982$1,281.64$10,594$274.49+$1.4KJSNSF
2$15,464$2,643.56$11,294$360.69+$4.2KJSNSF
3$22,420$5,873.53$12,133$476.91+$10.3KJSNSF
4$38,649$14,659.50$13,156$635.42+$25.5KJSNSF
5$84,858$43,503.79$14,432$854.61+$70.4KJSNSF
6$255,231$164,433.24$16,056$1,162.76+$239.2KJSNSF
7$1,124,503$851,405.69$18,175$1,604.53+$1.11MJSNSF
8$7,660,788$6,457,569.91$21,009$2,252.68+$7.64MJSNSF
9$83,930,491$75,733,447.92$24,911$3,229.73+$83.91MJSNSF
10$1,518,172,862$1,428,367,236.01$30,458$4,749.88+$1518.14MJSNSF

JSNSF vs JNJ: Complete Analysis 2026

JSNSFStock

J Sainsbury plc, together with its subsidiaries, engages in the food, general merchandise and clothing retailing, and financial services activities in the United Kingdom and the Republic of Ireland. It operates through three segments: Retail – Food, Retail – General Merchandise and Clothing, and Financial Services. The company operates various store formats, including convenience stores and supermarkets. It is also involved in the online grocery and general merchandise operations. As of March 5, 2022, the company operated 598 supermarkets, 809 convenience stores, 728 Argos stores, and 335 collection points, as well as 3 Habitat stores. In addition, it offers financial services, such as credit cards, scorecards, and personal loans; and home, car, pet, travel, and life insurance products. The company was founded in 1869 and is headquartered in London, the United Kingdom.

Full JSNSF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this JSNSF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

JSNSF vs SCHDJSNSF vs JEPIJSNSF vs OJSNSF vs KOJSNSF vs MAINJSNSF vs ABBVJSNSF vs MRKJSNSF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.